Innovation Pharmaceuticals Inc. Annual Return On Equity in % from 2012 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Innovation Pharmaceuticals Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
  • Innovation Pharmaceuticals Inc. Return On Equity for the quarter ending September 30, 2023 was -116 %, a 28.9% decline year-over-year.
  • Innovation Pharmaceuticals Inc. annual Return On Equity for 2023 was -113 %, a 3.07% decline from 2022.
  • Innovation Pharmaceuticals Inc. annual Return On Equity for 2022 was -109 %, a 49.2% increase from 2021.
  • Innovation Pharmaceuticals Inc. annual Return On Equity for 2021 was -215 %, a 206% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -113 -3.35 -3.07% Jul 1, 2022 Jun 30, 2023
2022 -109 +106 +49.2% Jul 1, 2021 Jun 30, 2022
2021 -215 -417 -206% Jul 1, 2020 Jun 30, 2021
2020 202 -6.98 -3.34% Jul 1, 2019 Jun 30, 2020
2019 209 -341 -62% Jul 1, 2018 Jun 30, 2019
2018 549 +3.68K Jul 1, 2017 Jun 30, 2018
2017 -3.13K -2.81K -881% Jul 1, 2016 Jun 30, 2017
2016 -319 -134 -72.6% Jul 1, 2015 Jun 30, 2016
2015 -185 +820 +81.6% Jul 1, 2014 Jun 30, 2015
2014 -1.01K -1.05K -2229% Jul 1, 2013 Jun 30, 2014
2013 47.2 -17.3 -26.8% Jul 1, 2012 Jun 30, 2013
2012 64.5 Jul 1, 2011 Jun 30, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.